The short version of nitric oxide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-20. Anything still debated is marked as such rather than presented as settled.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Standard practice for the solid form is storage at minus twenty degrees Celsius or colder, kept dry and away from light. Containers are usually sealed with a desiccant to limit moisture uptake. Reconstituted solutions are typically held at two to eight degrees Celsius and used within a short window, because potency can decline over days to weeks depending on the buffer and concentration. Freezing an already dissolved sample may help, though repeated thawing is discouraged. Specific shelf-life claims vary between suppliers and are rarely supported by published stability studies.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
Peptides are susceptible to hydrolysis, oxidation, and aggregation, and BPC-157 is no exception. The lyophilized powder form is generally more stable than a solution because residual moisture is low and molecular mobility is reduced. Once dissolved, the peptide is exposed to water, oxygen, and trace metal ions that accelerate degradation. Light exposure and repeated freeze-thaw cycles are also commonly cited as sources of loss. These general principles guide most handling recommendations found in supplier documentation.
By 1959, the average weight was around 12 kg (today, chainsaws typically weigh between 4 and 5 kg, with heavy-duty models ranging from 7 to 9 kg), and it quickly gained attention. McCulloch in North America started to produce chainsaws in 1948. The early models were heavy, two-person devices with long bars. Often, chainsaws were so heavy that they had wheels like dragsaws. Other outfits used driven lines from a wheeled power unit to drive the cutting bar. Carburettors featuring swivel and floating diaphragms were developed after the war, enabling modern chainsaws to operate in any orientation without the risk of flooding or fuel starvation. Additionally, the use of lighter materials played a crucial role in the advancement of the modern hand-held chainsaw. Logging operations use a variety of these specialized machinery, but hand felling with a cable skidder (where tractors and horses may still be utilized) continues to be a viable, cost-effective way to make a living as a logger. They are made in many sizes, from small electric saws intended for home and garden use, to large "lumberjack" saws. Members of military engineer units are trained to use chainsaws, as are firefighters to fight forest fires and to ventilate structure fires. Three main types of chainsaw sharpeners are used: handheld file, electric chainsaw, and bar-mounted. The first electric chainsaw was invented by Stihl in 1926.
Yellow kōji is used, among other things, for the production of soy sauce, miso, sake, tsukemono, jiang, makgeolli, meju, tapai, kōji-amazake, rice vinegar, mirin, shio koji and natto. Typically, for the production of soy sauce (shoyu), soybeans and sometimes also wheat are swollen in water, steamed, and possibly mixed with wheat bran roasted at 160–180 °C and ground. The enrichment with kōji creates a moist mash. There are three Aspergillus species that are used as yellow kōji:
Both enantiomers of alazocine have very low affinity for the sigma σ2 receptor (Ki = 13,694 nM and 4,581 nM for the (+)- and (−)-enantiomers, respectively, in rat brain membranes or rat PC12 cells). As such, due to its high affinity for the σ1 receptor, (+)-alazocine can be used to distinguish between the two sigma receptor subtypes in scientific research, for instance in radioligand binding assays. Taken together, (−)-alazocine is a selective partial agonist of the κ-opioid receptor, antagonist of the μ-opioid receptor, and to a far lesser extent agonist of the δ-opioid receptor with very low affinity for the sigma receptors, while (+)-alazocine is a selective agonist of the sigma σ1 receptor and to a lesser (~10-fold) extent antagonist of the NMDA receptor with low affinity for the opioid and sigma σ2 receptors.
== Mechanism of activation == Opioid receptors are a type of G protein–coupled receptor (GPCR). These receptors are distributed throughout the central nervous system and within the peripheral tissue of neural and non-neural origin. They are also located in high concentrations in the periaqueductal grey, locus coeruleus, and the rostral ventromedial medulla. The receptors consist of an extracellular amino acid N-terminus, seven trans-membrane helical loops, three extracellular loops, three intracellular loops, and an intracellular carboxyl C-terminus. Three GPCR extracellular loops provide a compartment where signalling molecules can attach to generate a response. Heterotrimeric G protein contain three different sub-units, which include an alpha (α) subunit, a beta (β) subunit, and a gamma (γ) sub-unit. The gamma and beta sub-units are permanently bound together, producing a single Gβγ sub-unit. Heterotrimeric G proteins act as 'molecular switches', which play a key role in signal transduction, because they relay information from activated receptors to appropriate effector proteins. All G protein α sub-units contain palmitate, which is a 16-carbon saturated fatty acid, that is attached near the N-terminus through a labile, reversible thioester linkage to a cysteine amino acid. It is this palmitoylation that allows the G protein to interact with membrane phospholipids due to the hydrophobic nature of the alpha sub-units. The gamma sub-unit is also lipid modified and can attach to the plasma membrane as well.
=== Disability and death === Due to distance, Hodgkin decided not to attend the 1987 Congress of the International Union of Crystallography in Australia. However, despite increasing frailty, she astounded close friends and family by going to Beijing for the 1993 Congress, where she was welcomed by all. She died in July 1994 after a stroke, at her husband's home in the village of Ilmington, near Shipston-on-Stour, Warwickshire.
Sources: en.wikipedia.org
Attacking with fresh troops, the 82nd broke through the Hindenburg line on 15 October. On 18 October, the 82nd Division relieved the 78th division at Champigneulle. Three days later it advanced to the Ravin aux Pierres. On 31 October, the 82nd, except the artillery, was relieved by the 77th Division and the 80th Division, and assembled in the Argonne Forest to regroup. On 10 November, it moved again to training areas in Bourmont, where it remained until the Armistice of 11 November 1918.
== Clinical significance == Melanoma - Cancer affecting melanocytes Melanocytic tumors Melanocytic tumors of uncertain malignant potential Vitiligo - Decreased number of melanocytes due to autoimmune destruction causing decreased melanin Albinism - Normal number of melanocytes, but decreased melanin production due to decreased tyrosinase activity or defective tyrosine transport Melasma (Chloasma) - Patchy hyperpigmentation of the skin Normal number of melanocytes with increased melanin production causing hyperpigmentation. Associated with pregnancy or oral contraceptive pill use. Addison disease Nevus depigmentosus
Although Southern Rhodesia never gained full Dominion status within the Commonwealth of Nations, Southern Rhodesians ruled themselves from the attainment of 'Responsible Government' in 1923. Its electoral register had property and education qualifications. Over the years various electoral arrangements made at a national and municipal level upheld these standards. For example, the franchise for the first Southern Rhodesian Legislative Council election in 1899 contained the following requirement:
==== English-language ==== A 2013 systematic review of the English-language case reports found that serious adverse events associated with acupuncture are rare, but that acupuncture is not without risk. Between 2000 and 2011 the English-language literature from 25 countries and regions reported 294 adverse events. The majority of the reported adverse events were relatively minor, and the incidences were low. For example, a prospective survey of 34,000 acupuncture treatments found no serious adverse events and 43 minor ones, a rate of 1.3 per 1000 interventions. Another survey found there were 7.1% minor adverse events, of which 5 were serious, amid 97,733 acupuncture patients. The most common adverse effect observed was infection (e.g. mycobacterium), and the majority of infections were bacterial in nature, caused by skin contact at the needling site. Infection has also resulted from skin contact with unsterilized equipment or with dirty towels in an unhygienic clinical setting. Other adverse complications included five reported cases of spinal cord injuries (e.g. migrating broken needles or needling too deeply), four brain injuries, four peripheral nerve injuries, five heart injuries, seven other organ and tissue injuries, bilateral hand edema, epithelioid granuloma, pseudolymphoma, argyria, pustules, pancytopenia, and scarring due to hot-needle technique.
== Diagnosis == The variety in symptoms, overlap with other disorders, and lack of awareness in medical professionals often complicate the diagnosis of coeliac disease by leading to a delay in the diagnosis. A diagnosis may take more than a decade after symptoms develop, and most people with coeliac disease remain undiagnosed. Delays in diagnosis can reduce quality of life, use more medical resources and increase risk of complications associated with the disease. Coeliac disease is diagnosed based on symptoms, blood tests, and biopsies of the small intestine. To make an accurate diagnosis, an individual must be consuming gluten, as the reliability of biopsies and blood tests reduces if a person is on a gluten-free diet. In those who have already reduced their gluten intake, reintroducing gluten (gluten challenge) may be required to reach an accurate diagnosis. Within months of eliminating gluten from one's diet, antibodies associated with coeliac disease decrease, meaning that gluten has to be reintroduced several weeks before diagnostic testing.
Sources: en.wikipedia.org
== Structure == The basement membrane was first described in skeletal muscle tissue in the 1800s. The beginnings of a molecular understanding only came about in the 1970s and 1980s. Epithelial cells are polarized. The surface of epithelial cells that face the lumen is the apical surface, and the surface facing the basement membrane is the basal surface. The basement membrane may be described as having two layers or laminae, an external basal lamina, facing the epithelium, and an internal basal lamina that faces the connective tissue. These two laminae are also known as the basal lamina and the reticular lamina. The cells in the internal basal membrane that are closest to the connective tissue show high rates of mitosis, needed to replace skin cell abrasions, and in the GI tract replacement of the cells exposed to digestive enzymes and gastric acid. In the skin the basement membrane is part of a more complex basement membrane zone. In the mucous membrane linings such as the gastric mucosa the basement membrane overlies loose connective tissue known as the lamina propria. The basement membrane is synthesized by cells on either side. One set of components are synthesized from the basal epithelial cells, and the other comes from the underlying connective tissue. Together the basement membrane contains glycoproteins – laminins, type IV collagen, and nidogen, and proteoglycans – perlecan, heparan sulfate proteoglycan, and agrin that blend together. Other components may include fibronectin and type XVIII collagen.
=== Laboratory synthesis === Heavy neutron irradiation of plutonium results in four major isotopes of einsteinium: 253Es (α-emitter; half-life 20.47 days, spontaneous fission half-life 7×105 years); 254mEs (β-emitter, half-life 39.3 hours), 254Es (α-emitter, half-life 276 days) and 255Es (β-emitter, half-life 39.8 days). An alternative route involves bombardment of uranium-238 with high-intensity nitrogen or oxygen ion beams. 247Es (half-life 4.55 min) was produced by irradiating 241Am with carbon or 238U with nitrogen ions. The latter reaction was first realized in 1967 in Dubna, Russia, and the involved scientists were awarded the Lenin Komsomol Prize. 248Es was produced by irradiating 249Cf with deuterium ions. It mainly β-decays to 248Cf with a half-life of 25±5 minutes, but also releases 6.87-MeV α-particles; the ratio of β's to α-particles is about 400.
== Overview of religious studies work as characterized by Klaus von Stosch == Translated from German into English by Friederike von Schwerin-High (professor of German studies at Pomona College since 2005; PhD from UMass Amherst in comparative literature; research interests: narrative theory, translation studies and eighteenth-century literature). Klaus von Stosch, a comparative theologian from Bonn who has held the Chair of Systematic Theology at the University of Bonn since the 2021/2022 winter semester, has been familiar with Kermani's religious studies work since its inception and classifies it as follows: Even though Kermani does not consider himself a theologian, his texts on Islam and religious studies clearly go beyond a purely descriptive approach. In many places, the texts are a plea for a new take on the Koran and on Islamic tradition, but also for a more comprehensive view of other religions. Emphasizing the mystical, experiential dimension of religions, his texts tend to approach religion on an aesthetic level. However, his writings do not only address the union of human beings with God, which is paramount tomysticism, and to the associated notions of love and happiness. He is also concerned with the glory and terror of God, in other words, with all aspects of God's inexpressible mystery. From a theological point of view, Kermani attaches importance to the unity of God and the unity of all being in a decidedly classical sense. Everything comes from the One and returns to it—like the breath of human beings.
== Instruments == Most current medical laboratories now have highly automated analyzers to accommodate the high workload typical of a hospital laboratory, and accept samples for up to about 700 different kinds of tests. Even the largest of laboratories rarely do all these tests themselves, and some must be referred to other labs. Tests performed are closely monitored and quality controlled.
== Side effects == Side effects experienced with this product will resemble those of other benzodiazepines. Drowsiness and asthenia are common side effects. There has been a report of reversible hepatitis caused by clotiazepam.
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.